Real-world glycaemic outcomes of >12,200 adults with type 1 diabetes using the Omnipod® 5 Automated Insulin Delivery (AID) system with cloud-based data management

被引：0
|
作者：
Wilmot, E. G. [1 ]
Lal, R. A. [2 ]
Aleppo, G. [3 ]
Huyett, L. M. [4 ]
Snow, K. [4 ]
Mendez, J. J. [4 ]
Hadjiyianni, I. [4 ]
Ly, T. T. [4 ]
机构：
[1] Univ Nottingham, Royal Derby Hosp, Acad Unit Translat Med Sci, Sch Med, Derby, England
[2] Stanford Sch Med, Stanford, CA USA
[3] Northwestern Univ, Evanston, IL USA
[4] Insulet Corp, Acton, MA USA
来源：
DIABETOLOGIA | 2023年 / 66卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
225
引用
收藏
页码：S119 / S120
页数：2
相关论文
共 50 条
  • [41] FREQUENT BOLUSING IS ASSOCIATED WITH BETTER GLYCEMIC OUTCOMES IN 4,483 ADULTS WITH TYPE 1 DIABETES USING THE OMNIPOD INSULIN MANAGEMENT SYSTEM
    Hirsch, I.
    Weinstock, R.
    Huyett, L.
    Jantz, J.
    Chang, A.
    Vienneau, T.
    Ly, T.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2020, 22 : A27 - A28
  • [42] Glycemic Outcomes with the Omnipod 5 Automated Insulin Delivery (AID) System Stratified by Baseline Hypoglycemia Risk among People with Type 1 Diabetes (T1D) Ages 2 to 70 Years
    Forlenza, Gregory P.
    Bode, Bruce W.
    Carlson, Anders L.
    Criego, Amy B.
    Brown, Sue A.
    Weinstock, Ruth S.
    Hansen, David W.
    Buckingham, Bruce A.
    Mehta, Sanjeev N.
    Laffel, Lori M.
    Sherr, Jennifer
    Levy, Carol J.
    Hirsch, Irl B.
    Macleish, Sarah A.
    Desalvo, Daniel
    Shah, Viral
    Bhargava, Anuj
    Jones, Thomas C.
    Aleppo, Grazia
    Huyett, Lauren M.
    Ly, Trang T.
    DIABETES, 2022, 71
  • [43] Regular users of temporary basal rate or extended bolus have better glycaemic outcomes in 12,823 Omnipod® insulin management system users with type 1 diabetes
    Weinstock, R.
    Hirsch, I.
    Forlenza, G.
    Desalvo, D.
    Srinivasan, B.
    Jantz, J.
    Huyett, L.
    Chang, A.
    Vienneau, T.
    Ly, T.
    DIABETIC MEDICINE, 2021, 38
  • [44] Glycemic and psychosocial outcomes with automated insulin delivery system use in adolescents and young adults with type 1 diabetes over 12 months
    Waterman, L.
    Sakamoto, C.
    Polsky, S.
    Berget, C.
    Cobry, E.
    HORMONE RESEARCH IN PAEDIATRICS, 2024, 97 : 299 - 299
  • [45] GLYCEMIC PROFILES AND TREATMENT PATTERNS: REAL-WORLD DATA FROM 13,109 PEOPLE IN EUROPE AND CANADA WITH DIABETES USING A TUBELESS INSULIN PUMP WITH CLOUD-BASED DATA MANAGEMENT
    Danne, T.
    Wilmot, E.
    Lauand, F.
    Huyett, L.
    Jantz, J.
    Chang, A.
    Lowen, S.
    Vienneau, T.
    Ly, T.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2021, 23 : A50 - A50
  • [46] Changes in ambulatory glucose profile in people with type 1 diabetes using an automated insulin delivery system - two year follow-up retrospective analysis of real-world data
    Mueller-Korbsch, Michael
    Kietaibl, Antonia
    Haufe, Yves
    Fasching, Peter
    DIABETES EPIDEMIOLOGY AND MANAGEMENT, 2023, 11
  • [47] GLP-1 Receptor Agonists in Overweight and Obese Individuals With Type 1 Diabetes Using an Automated Insulin Delivery Device: A Real-World Study
    Holmager, Pernille
    Christensen, Merete Bechmann
    Norgaard, Kirsten
    Schmidt, Signe
    JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY, 2024,
  • [48] GLP-1 Receptor Agonists in Overweight and Obese Individuals With Type 1 Diabetes Using an Automated Insulin Delivery Device: A Real-World Study
    Holmager, Pernille
    Christensen, Merete Bechmann
    Norgaard, Kirsten
    Schmidt, Signe
    JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY, 2025, 19 (02): : 286 - 291
  • [49] Patient-reported outcomes for 2,335 adults with type 2 diabetes using the Omnipod® Insulin Management System show glycaemic improvement over the first 90 days of use
    Huyett, L. M.
    Carlson, A.
    Jantz, J.
    Chang, A.
    Vienneau, T.
    Ly, T. T.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S343 - S344
  • [50] PERFORMANCE OF OMNIPOD® 5 AUTOMATED INSULIN DELIVERY SYSTEM AT SPECIFIC GLUCOSE TARGETS FROM 110-150MG/DL OVER THREE MONTHS IN ADULTS AND ADOLESCENTS WITH TYPE 1 DIABETES
    Bode, B.
    Levy, C.
    Brown, S.
    Carlson, A.
    Shah, V.
    Pinsker, J.
    Bhargava, A.
    Mehta, S.
    Laffel, L.
    Jones, T.
    Aleppo, G.
    Forlenza, G.
    Ly, T.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2021, 23 : A14 - A14
12345